Olink Holding AB (publ) (NASDAQ:OLK) Earns “Equal Weight” Rating from Morgan Stanley

Morgan Stanley restated their equal weight rating on shares of Olink Holding AB (publ) (NASDAQ:OLK) in a research report sent to investors on Tuesday, Benzinga reports. They currently have a $26.00 price objective on the stock.

Separately, Canaccord Genuity Group reissued a hold rating and issued a $26.00 price objective on shares of Olink Holding AB (publ) in a report on Tuesday.

Olink Holding AB (publ) Stock Performance

Shares of OLK stock opened at $23.51 on Tuesday. The company has a market capitalization of $2.92 billion, a price-to-earnings ratio of -94.04 and a beta of 0.49. Olink Holding AB has a 52 week low of $14.10 and a 52 week high of $26.01. The company has a 50-day simple moving average of $23.90 and a 200 day simple moving average of $23.01.

Institutional Trading of Olink Holding AB (publ)

A number of institutional investors have recently bought and sold shares of the business. Assetmark Inc. boosted its holdings in Olink Holding AB (publ) by 30.5% in the 4th quarter. Assetmark Inc. now owns 2,874 shares of the company’s stock valued at $72,000 after purchasing an additional 672 shares during the period. UBS Group AG raised its position in shares of Olink Holding AB (publ) by 24.1% in the 1st quarter. UBS Group AG now owns 7,127 shares of the company’s stock valued at $161,000 after buying an additional 1,382 shares in the last quarter. Gilder Gagnon Howe & Co. LLC raised its position in shares of Olink Holding AB (publ) by 2.6% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 75,773 shares of the company’s stock valued at $1,923,000 after buying an additional 1,889 shares in the last quarter. New York State Common Retirement Fund raised its position in shares of Olink Holding AB (publ) by 3.7% in the 3rd quarter. New York State Common Retirement Fund now owns 67,166 shares of the company’s stock valued at $991,000 after buying an additional 2,368 shares in the last quarter. Finally, Barometer Capital Management Inc. acquired a new position in shares of Olink Holding AB (publ) in the 4th quarter valued at approximately $116,000. Institutional investors own 30.19% of the company’s stock.

Olink Holding AB (publ) Company Profile

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.